611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
Teens' Heart Risk From COVID Far Exceeds That of Vaccination: StudyCould COVID-19 Accelerate Alzheimer's Symptoms?New Data Details Dangers of Delta Variant, Even for the VaccinatedCDC Now Says Vaccinated Should Be Tested After COVID Exposure, Even Without SymptomsWhy Strokes Can Affect Women, Men DifferentlyMore Than Half of Americans Plagued by Back, Leg PainPfizer Says 3rd Shot of Vaccine Boosts COVID ProtectionVitamin D May Lower Black Women's Odds for COVID-19Primary Care Doctors Often Miss Heart Failure in Women, Black PatientsBogus Info on Cancer Common Online, and It Can HarmDelta Variant Spreads More Easily, Causing CDC Change on Indoor MaskingSevere COVID for People Under 45: Who's Most at Risk?The Heat Is On: Staying Safe When Temperatures SoarWho's Most Likely to Refuse a COVID Vaccine?Second COVID Shot Safe in Folks Who Had Allergic Reaction to FirstHigh Blood Pressure: Which Drug Works Best for You?Pfizer, Moderna to Expand Vaccine Studies in Young ChildrenFederal, State Moves Begin to Mandate COVID Vaccines for WorkersCan COVID Transmit Easily on Crowded School Buses?Worried About Delta-Linked 'Breakthrough' Infections? Experts Explain the RisksMajor Medical Groups Call for Mandatory COVID Vaccination for Health WorkersU.S. to Stick With International Travel RestrictionsSurvey Finds U.S. Parents Split on COVID Vaccination for Kids Under 12Most Unvaccinated Americans Want to Stay That Way: PollIt's Tick Season: Protect Yourself From Lyme DiseaseHigh-Tech Exoskeletons Improve Bowel Function in People With Spinal Cord Injury'Superbug' Fungus Spreads Among Vulnerable in Two U.S. CitiesVaccinations Start to Climb in States Hit Hard by Delta VariantAs Olympics Begin, Tokyo Posts Highest Number of New COVID Cases in Six MonthsVirtual Roller Coaster Ride Study Brings New Insights Into MigraineBiden Says Full Approval for COVID Vaccines Coming SoonPfizer Vaccine Offers 88% Protection Against Delta Variant, But 2 Doses NeededSecret Weapon: Why the 2nd Dose of Pfizer Vaccine Is So CrucialIn a First for the Continent, Pfizer COVID-19 Vaccine Will Be Produced in South AfricaLockdowns' Effects on Health Still Less Than Harm From Pandemic: ExpertsCOVID Drove Biggest Drop in U.S. Life Expectancy Since World War IIJ&J Vaccine Weak Against Delta Variant, 2nd Dose May Be NeededDouble Trouble: Wildfire Smoke Could Boost Odds for COVID's SpreadStatin Users May Have Added Protection Against Severe COVID-19Severe COVID in Kids: Rare, but Brain Issues Can ResultOne-Dose Blood Thinner Could Slash Blood Clot Risk After Knee ReplacementU.S. Issues Toughest Travel Alert for Britain As COVID Cases There ClimbPediatricians' Group: All School Kids, Staff Should Continue to Wear MasksGeneticists Probe Origins of Painful Cluster HeadachesAny COVID Infection Leaves Strong Antibody Levels in KidsMany Hit Hard by Pandemic Now Swamped by Medical DebtU.S. Surgeon General Backs Local Mask Mandates When NeededMake Summer Camp Safe for Your Child With Asthma, AllergiesCanada May Open Borders to Fully Vaccinated Americans by Mid-AugustCDC Advisors to Discuss 3rd COVID Vaccine Dose for Immunocompromised
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

CDC Advisors to Discuss 3rd COVID Vaccine Dose for Immunocompromised

HealthDay News
by Robert Preidt
Updated: Jul 16th 2021

new article illustration

FRIDAY, July 16, 2021 (HealthDay News) -- Giving a third dose of COVID-19 vaccines to adults with weakened immune systems — the immunocompromised — will be up for discussion during a U.S. Centers for Disease Control and Prevention advisory panel meeting next week.

At the meeting scheduled for July 22, the Advisory Committee on Immunization Practices will focus on the 2% to 4% of U.S. adults with weakened immune systems. These include organ transplant recipients, people receiving cancer treatments, and those living with rheumatologic conditions, HIV and leukemia, the Washington Post reported.

The director of the U.S. National Institutes of Health doesn't consider giving an additional dose of currently approved two-dose vaccines to immunocompromised people a "booster" shot.

"I wouldn't call that a booster," Francis Collins said, the Post reported. "I would call that trying to get the primary immunization into the effective place."

Advisory committee member Camille Kotton, a transplant-medicine physician at Massachusetts General Hospital in Boston, expressed support for the idea.

"From my perspective as someone who takes care of immunocompromised people, including organ transplant recipients, who seem to have a diminished response to vaccination, and based on the data we have seen recently … it does seem like an additional dose of vaccine would be appropriate for this population. And as far as we can tell, it would be safe and likely to augment immunity," Kotton told the Post.

But not all experts agree.

"I haven't seen evidence that a booster would be indicated for anybody, including the immunocompromised," said Helen Boucher, an infectious disease physician at Tufts Medical Center in Boston.

"A lot of that data is still emerging," Boucher told the Post.

Booster shots have become a hot topic since Pfizer-BioNTech said last week it would seek emergency use authorization for a third shot of its two-dose vaccine amid growing concerns about the highly transmissible Delta variant, but U.S. health officials have said a third dose is not widely needed, the Post reported.

Critics, including the World Health Organization, say drug companies like Pfizer should focus on getting desperately needed shots to billions of people in the developing world, not boosters for already-vaccinated people in wealthy countries.

Next week's CDC advisory panel meeting won't deal with Pfizer-BioNTech's request for regulatory approval of a third booster dose. It will focus on updating clinical considerations for coronavirus vaccines, something that doesn't require a panel vote.

This week, Israel said it would start giving a third dose of the Pfizer vaccine to severely immunocompromised adults, and Britain plans to start giving booster shots in September, first to those with weakened immune systems, people older than 70 and front-line health care workers, the Post reported.

More information

Find out more about the COVID-19 vaccine and the immunocompromised at Johns Hopkins University.

SOURCE: Washington Post